Psychosocial effects of appearance changes due to cancer treatment and needs for information and supportive care in Japanese cancer patients.
Derriford Appearance Scale 59 (DAS59)
appearance care
chemotherapy
Journal
Asia-Pacific journal of clinical oncology
ISSN: 1743-7563
Titre abrégé: Asia Pac J Clin Oncol
Pays: Australia
ID NLM: 101241430
Informations de publication
Date de publication:
Oct 2020
Oct 2020
Historique:
received:
25
07
2019
accepted:
27
02
2020
pubmed:
15
4
2020
medline:
28
10
2020
entrez:
15
4
2020
Statut:
ppublish
Résumé
Cancer treatment can alter patient appearance, leading to psychological, social, and behavioral issues. This study aimed to investigate distress and difficulties related to appearance concerns in Japanese cancer patients and to identify information and support needs among them. We conducted a questionnaire survey using the Derriford Appearance Scale 59 (DAS59) among cancer patients with a prior history of chemotherapy, molecular targeted therapy, or immunotherapy, who were recruited from the Departments of Medical Oncology and Psychosomatic Medicine, Kindai University Hospital. Participants were 114 patients with a mean age of 62.9 years; 70.2% were female, 86.0% had metastatic or locally advanced unresectable cancer, and 78.1% had concerns about some aspect of their appearance. Mean DAS59 full-scale score was 77.7 ± 36.4. Younger and female participants were found to have higher full-scale scores in univariate analysis (P < .05 for both), and younger participants were found to have higher full-scale scores in multivariate analysis (P < .05). DAS59 scores had a wide distribution, suggesting that psychological distress due to appearance changes showed large individual differences. Young and female patients tended to have high DAS59 full-scale scores, but some older and male patients also had high scores. Basic information regarding appearance changes should be provided to all patients before initiating cancer treatment. Both information provision prior to treatment and care at the time of actual appearance changes are important, and should be handled through a multidisciplinary approach.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e185-e191Subventions
Organisme : Kindai University
ID : SR-14
Informations de copyright
© 2020 John Wiley & Sons Australia, Ltd.
Références
Nozawa K, Shimizu C, Kakimoto M, et al. Quantitative assessment of appearance changes and related distress in cancer patients. Psychooncology. 2013;22(9):2140-2147.
Wallace ML, Harcourt D, Rumsey N, Foot A. Managing appearance changes resulting from cancer treatment: resilience in adolescent females. Psychooncology. 2007;16(11):1019-1027.
Lemieux J, Maunsell E, Provencher L. Chemotherapy-induced alopecia and effects on quality of life among women with breast cancer: a literature review. Psychooncology. 2008;17(4):317-328.
Harris DL, Carr AT. Prevalence of concern about physical appearance in the general population. Br J Plast Surg. 2001;54(3):223-226.
Liu HE. Changes of satisfaction with appearance and working status for head and neck tumour patients. J Clin Nurs. 2008;17(14):1930-1938.
Moss TP. The relationships between objective and subjective ratings of disfigurement severity, and psychological adjustment. Body Image. 2005;2(2):151-159.
Harris DL, Carr AT. The Derriford Appearance Scale (DAS59): a new psychometric scale for the evaluation of patients with disfigurements and aesthetic problems of appearance. Br J Plast Surg. 2001;54(3):216-222.
Carr T, Moss T, Harris D. The DAS24: a short form of the Derriford Appearance Scale DAS59 to measure individual responses to living with problems of appearance. Br J Health Psychol. 2005;10(Pt 2):285-298.
Djan R, Penington A. A systematic review of questionnaires to measure the impact of appearance on quality of life for head and neck cancer patients. J Plast Reconstr Aesthet Surg. 2013;66(5):647-659.
Nozawa K. Characteristics of concern about physical appearance of general people using appearance-related QOL scale DAS 59. Proceedings of the 72th Annual Convention of the Japanese Psychological Association 2008 (in Japanese).
Jenkins V, Fallowfield L, Saul J. Information needs of patients with cancer: results from a large study in UK cancer centres. Br J Cancer. 2001;84(1):48-51.
Tucker CA, Martin MP, Jones RB. Health information needs, source preferences and engagement behaviours of women with metastatic breast cancer across the care continuum: protocol for a scoping review. BMJ Open. 2017;7(2):013619.
Keiko N, Kazuhiro H, Nobuaki N, et al. Development of the Japanese version of Derriford Appearance Scale DAS59: a QOL index for the people who have problems of appearance. J Jpn Soc Plast Reconstr Surg. 2008;28(7):440-448.
Hori M, Matsuda T, Shibata A, Katanoda K, Sobue T, Nishimoto H. Cancer incidence and incidence rates in Japan in 2009: a study of 32 population-based cancer registries for the Monitoring of Cancer Incidence in Japan (MCIJ) project. Jpn J Clin Oncol. 2015;45(9):884-891.
Kanda Y. Investigation of the freely available easy-to-use software ‘EZR’ for medical statistics. Bone Marrow Transplant. 2013;48(3):452-458.
Frick MA, Vachani CC, Bach C, et al. Survivorship and the chronic cancer patient: patterns in treatment-related effects, follow-up care, and use of survivorship care plans. Cancer. 2017;123(21):4268-4276.